Watertown, MA, United States of America

Chris Oalmann



Average Co-Inventor Count = 6.6

ph-index = 1

Forward Citations = 5(Granted Patents)


Location History:

  • Waltham, MA (US) (2004)
  • Watertown, MA (US) (2009 - 2012)

Company Filing History:


Years Active: 2004-2012

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Chris Oalmann: Innovator in Cyclin-Dependent Kinase Inhibitors

Introduction

Chris Oalmann is a notable inventor based in Watertown, MA (US), recognized for his contributions to the field of biotechnology. He holds a total of five patents, showcasing his innovative approach to scientific challenges.

Latest Patents

Among his latest patents, Oalmann has developed inhibitors of cyclin-dependent kinases (cdks), which are crucial for regulating the cell cycle. These novel compounds are designed to inhibit cdk/cyclin complexes, thereby modulating cell-cycle progression. This innovation has significant implications for treating disorders associated with excessive cell proliferation, such as cancer. The inhibitors are capable of controlling cell growth and differentiation, making them valuable in therapeutic applications.

Career Highlights

Throughout his career, Chris Oalmann has worked with various organizations, including Agennix USA Inc. His work has focused on advancing the understanding and application of cyclin-dependent kinase inhibitors in medical science.

Collaborations

Oalmann has collaborated with notable professionals in his field, including Nicholas Bockovich and Arthur F Kluge. These partnerships have contributed to the development and refinement of his innovative ideas.

Conclusion

Chris Oalmann's work in developing cyclin-dependent kinase inhibitors represents a significant advancement in biotechnology. His contributions have the potential to impact the treatment of various diseases, highlighting the importance of innovation in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…